Long-term results of a randomized controlled trial of T2 versus T2-T3 ablation in endoscopic thoracic sympathectomy for palmar hyperhidrosis.

摘要: Despite good short-term results and patient satisfaction with endoscopic thoracic sympathectomy (ETS), there has been much debate on the level of for treatment palmar hyperhidrosis (PH) in terms long-term clinical outcomes. The aim study was to analyze recurrence compensatory (CH) rates ETS, comparing single-level T2 against multi-level T2–T3 ablation single patients. Patients who had undergone PH unilateral contralateral ETS were retrospectively reviewed. They subjected telephone interview using standardized set script questionnaire a scoring system similar disease severity scale. All patients evaluated comparison symptom resolution, site CH, rates. To compare between T2–T3, one side is matched ipsilateral CH occurrence. Twenty-two mean age 36.5 years could be reached. follow-up 8 years (range 38–153 months). global rate 18 %. observed 20 (91 %) patients, trunk compensation most common (18/22–82 %), followed by lower limb (14/22–64 %) axilla (10/22–45 %). Overall, 72.8 % (16) satisfied operation. Among six not satisfied, two reported symptoms, while four experienced some form compensation. There no absolute difference sweating bilaterally PH. also symmetrical all (T2) (T2–T3) ETSs long term.